Skip to content

TG Therapeutics

US · TGTX #1638 by market cap Listed 1970
63.34 -1.54 -2.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78
    Market Newswire · 2026/9/22
  • Rating change
    J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $72
    Market Newswire · 2026/8/11
  • Rating change
    B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86
    Market Newswire · 2026/9/2
  • TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/11/10
  • BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating
    Market Newswire · 2026/11/11
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/7/6
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $78
    Market Newswire · 2026/8/4
  • Rating change
    Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $83
    Market Newswire · 2026/7/14
  • Rating change
    TG Therapeutics (TGTX) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/7/13
  • Evercore Initiates TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $71
    Market Newswire · 2026/11/10
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $21
    Market Newswire · 2026/8/5
  • Rating change
    TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $75
    Market Newswire · 2026/7/22
  • J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating
    Market Newswire · 2026/10/27
  • Rating change
    TG Therapeutics (TGTX) Receives a Buy From H.C. Wainwright
    TipRanks · 2026/9/22
  • Rating change
    Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83
    Market Newswire · 2026/6/23
  • Rating change
    B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)
    TipRanks · 2026/9/2
  • J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $72
    Market Newswire · 2026/11/10
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $20
    Market Newswire · 2026/7/7
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $77
    Market Newswire · 2026/7/13
  • Rating change
    J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $65
    Market Newswire · 2026/7/16
  • Rating change
    TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/4
  • Rating change
    Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $41
    Market Newswire · 2026/5/28
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $17
    Market Newswire · 2026/6/4
  • Rating change
    Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Maintains Target Price $41
    Market Newswire · 2026/6/4
  • Rating change
    J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating
    Market Newswire · 2026/5/28

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.

TG Therapeutics discussion 0 comments

Add a comment